DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
SAFINGOL
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SAFINGOL
×
Maximum Phase:
1
First Approval:
None
UNII:
OWA98U788S
Molecule Type:
Small molecule
Molecular Formula:
C18H39NO2
Molecular Weight:
301.52
AlogP:
4.15
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
16.0
Source:
GSK1614235
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GSK1614235
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)
1
Small molecule
Investigational
Unknown
Unknown
Acquired Immunodeficiency Syndrome
Unknown
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)
×
Maximum Phase:
1
First Approval:
None
UNII:
HHT01ZNK31
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HUMIK-BETA-1
1
Antibody
Investigational
Unknown
Unknown
Celiac Disease; HTLV-I Infections; Leukemia, Large Granular Lymphocytic
Interleukin-2 receptor beta chain inhibitor
HUMIK-BETA-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG6029
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG6029
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEDI-570
1
Antibody
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
Inducible T-cell costimulator inhibitor
MEDI-570
×
Maximum Phase:
1
First Approval:
None
UNII:
G9F0G3YL28
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-06273340
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-06273340
×
Maximum Phase:
1
First Approval:
None
UNII:
I136775ABW
Molecule Type:
Small molecule
Molecular Formula:
C23H22ClN7O3
Molecular Weight:
479.93
AlogP:
2.6
PSA:
148.91
HBD:
3.0
HBA:
#RotB:
7.0
Source:
NERINDOCIANINE
1
Small molecule
Investigational
Unknown
Unknown
Wounds and Injuries
Unknown
NERINDOCIANINE
×
Maximum Phase:
1
First Approval:
None
UNII:
1GZ5G85KVT
Molecule Type:
Small molecule
Molecular Formula:
C44H52N2O16S5
Molecular Weight:
1025.23
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ETIGILIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
T-cell immunoreceptor with Ig and ITIM domains inhibitor
ETIGILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
FC1ZF28VIT
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIMOTAXEL
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SIMOTAXEL
×
Maximum Phase:
1
First Approval:
None
UNII:
E1M30YOE59
Molecule Type:
Small molecule
Molecular Formula:
C46H57NO15S
Molecular Weight:
896.02
AlogP:
4.67
PSA:
230.52
HBD:
4.0
HBA:
#RotB:
11.0
Source:
DOTAMTATE PB-212
1
Unknown
Investigational
Unknown
Unknown
Neuroendocrine Tumors
Unknown
DOTAMTATE PB-212
×
Maximum Phase:
1
First Approval:
None
UNII:
E9N7QV53AK
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1642.67
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
NONA-L-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NONA-L-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
N6022
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Cystic Fibrosis
Alcohol dehydrogenase class III inhibitor
N6022
×
Maximum Phase:
1
First Approval:
None
UNII:
80LIU5P95D
Molecule Type:
Small molecule
Molecular Formula:
C24H22N4O3
Molecular Weight:
414.47
AlogP:
3.75
PSA:
103.14
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PAPAIN
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PAPAIN
×
Maximum Phase:
1
First Approval:
None
UNII:
A236A06Y32
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RXDX-105
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RXDX-105
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROFILNINE SD
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PROFILNINE SD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SARS-COV
1
Unknown
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
SARS-COV
×
Maximum Phase:
1
First Approval:
None
UNII:
R7D54R07N5
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VACCINIA IMMUNE GLOBULIN
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
VACCINIA IMMUNE GLOBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RP-6530
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Lymphoma, T-Cell, Cutaneous
PI3-kinase p110-delta subunit inhibitor
RP-6530
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NUMIDARGISTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms
Unknown
NUMIDARGISTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
IFD73D535A
Molecule Type:
Small molecule
Molecular Formula:
C11H22BN3O5
Molecular Weight:
287.12
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BUTHIONINE SULFOXIMINE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma; Neuroblastoma
Unknown
BUTHIONINE SULFOXIMINE
×
Maximum Phase:
1
First Approval:
None
UNII:
LW4108Q0BV
Molecule Type:
Small molecule
Molecular Formula:
C8H18N2O3S
Molecular Weight:
222.31
AlogP:
0.64
PSA:
104.24
HBD:
3.0
HBA:
#RotB:
7.0
Source:
TAPOTOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
TAPOTOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
97W7N9T08G
Molecule Type:
Small molecule
Molecular Formula:
C33H41ClN2O5S
Molecular Weight:
613.22
AlogP:
5.9
PSA:
84.94
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ABC-008
1
Unknown
Investigational
Unknown
Unknown
Myositis, Inclusion Body
Unknown
ABC-008
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GET-73
1
Small molecule
Investigational
Unknown
Unknown
Alcoholism
Unknown
GET-73
×
Maximum Phase:
1
First Approval:
None
UNII:
U5CLZ223FH
Molecule Type:
Small molecule
Molecular Formula:
C13H16F3NO2
Molecular Weight:
275.27
AlogP:
2.75
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
6.0
Source:
JNJ-68284528
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
JNJ-68284528
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FXR-450
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FXR-450
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-05230907
1
Unknown
Investigational
Unknown
Unknown
Cerebral Hemorrhage
Unknown
PF-05230907
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IOMAZENIL
1
Small molecule
Investigational
Unknown
Unknown
Cognitive Dysfunction; Schizophrenia
Unknown
IOMAZENIL
×
Maximum Phase:
1
First Approval:
None
UNII:
7DVX185FLQ
Molecule Type:
Small molecule
Molecular Formula:
C15H14IN3O3
Molecular Weight:
411.2
AlogP:
2.24
PSA:
64.43
HBD:
0.0
HBA:
#RotB:
2.0
Source:
NG-NITRO-L-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NG-NITRO-L-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMG-224
1
Unknown
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
AMG-224
×
Maximum Phase:
1
First Approval:
None
UNII:
Y69B45U0TK
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AG-270
1
Unknown
Investigational
Unknown
Unknown
Lymphoma
Unknown
AG-270
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DHES0815A
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DHES0815A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMP-110
1
Unknown
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Unknown
AMP-110
×
Maximum Phase:
1
First Approval:
None
UNII:
7J6GS9QIF0
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
.ALPHA.-PYRROLIDINONONANOPHENONE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
.ALPHA.-PYRROLIDINONONANOPHENONE
×
Maximum Phase:
1
First Approval:
None
UNII:
S3FKL8RY1D
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO
Molecular Weight:
287.45
AlogP:
4.69
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
9.0
Source:
LETRAZURIL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LETRAZURIL
×
Maximum Phase:
1
First Approval:
None
UNII:
U8736VCB22
Molecule Type:
Small molecule
Molecular Formula:
C17H9Cl2FN4O2
Molecular Weight:
391.19
AlogP:
3.02
PSA:
91.54
HBD:
1.0
HBA:
#RotB:
3.0
Source:
1
2
…
101
102
103
104
105
106
107
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA